IS5663A - Samsetning sem samanstendur af L-karnitíni eða alkanóýl L-karnitíni og NADH og/eða NADHP - Google Patents

Samsetning sem samanstendur af L-karnitíni eða alkanóýl L-karnitíni og NADH og/eða NADHP

Info

Publication number
IS5663A
IS5663A IS5663A IS5663A IS5663A IS 5663 A IS5663 A IS 5663A IS 5663 A IS5663 A IS 5663A IS 5663 A IS5663 A IS 5663A IS 5663 A IS5663 A IS 5663A
Authority
IS
Iceland
Prior art keywords
carnitine
nadhp
nadh
alkanoyl
composition
Prior art date
Application number
IS5663A
Other languages
English (en)
Icelandic (is)
Inventor
Cavazza Claudio
Original Assignee
Sigma-Tau Healthscience S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Healthscience S.P.A. filed Critical Sigma-Tau Healthscience S.P.A.
Publication of IS5663A publication Critical patent/IS5663A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS5663A 1998-04-17 2000-10-13 Samsetning sem samanstendur af L-karnitíni eða alkanóýl L-karnitíni og NADH og/eða NADHP IS5663A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98RM000238A IT1299161B1 (it) 1998-04-17 1998-04-17 Composizione comprendente l-carnitina o un'alcanoil l-carnitina e nadh e/o nadph
PCT/IT1999/000088 WO1999053921A1 (en) 1998-04-17 1999-04-14 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph

Publications (1)

Publication Number Publication Date
IS5663A true IS5663A (is) 2000-10-13

Family

ID=11405812

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5663A IS5663A (is) 1998-04-17 2000-10-13 Samsetning sem samanstendur af L-karnitíni eða alkanóýl L-karnitíni og NADH og/eða NADHP

Country Status (17)

Country Link
EP (1) EP1071424A1 (hu)
JP (1) JP2002512191A (hu)
KR (1) KR20010042765A (hu)
CN (1) CN1299283A (hu)
AU (1) AU750645B2 (hu)
BR (1) BR9909712A (hu)
CA (1) CA2328331A1 (hu)
EE (1) EE200000601A (hu)
HU (1) HUP0101914A3 (hu)
IL (1) IL139014A0 (hu)
IS (1) IS5663A (hu)
IT (1) IT1299161B1 (hu)
NO (1) NO20005128L (hu)
PL (1) PL343482A1 (hu)
SK (1) SK15442000A3 (hu)
TR (1) TR200002894T2 (hu)
WO (1) WO1999053921A1 (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252309B2 (en) 2000-04-04 2012-08-28 Sigma-Tau Industrie Farmaceutiche Riunite Spa Dietary supplement energy-providing to skeletal muscles
DE10326822A1 (de) * 2003-06-11 2005-01-05 Herzpharma Vita-Check Diagnosegeräte GmbH Mittel zur Nahrungsergänzung, dieses Mittel enthaltende pharmazeutische Präparate und Verwendungen des Mittels
BRPI0721698A2 (pt) * 2007-05-11 2013-01-22 Sigma Tau Ind Famaceutiche Riunite S P A gel étil para a liberaÇço de ingredientes ativos cosmÉticos
AU2010286348A1 (en) * 2009-08-31 2012-03-22 University Of South Australia Methods for diagnosis and treatment of chronic fatigue syndrome
CN104306390A (zh) * 2014-10-23 2015-01-28 苏州人本药业有限公司 还原型辅酶ⅱ的用途
CN104840479A (zh) * 2015-02-17 2015-08-19 苏州人本药业有限公司 Nadph在制备治疗心脏疾病药物中的应用
WO2019119445A1 (zh) * 2017-12-22 2019-06-27 邦泰生物工程(深圳)有限公司 一种nadh复方组合物及其制剂和应用
CA3097412A1 (en) 2018-04-20 2019-10-24 Pacotrade Ag Device for shredding of deep-frozen food products provided in block form
CN109170907A (zh) * 2018-08-30 2019-01-11 泓博元生命科技（深圳）有限公司 一种含有nmn的组合物、应用及运动饮料的制备方法
CN109105702A (zh) * 2018-08-30 2019-01-01 泓博元生命科技（深圳）有限公司 一种含有nadh的组合物、应用及能量补充剂的制备方法
SG11202103646UA (en) * 2018-10-10 2021-05-28 So Ngor Sally Leung Health-care product composition for enriching asthenic disease, preparation method therefor and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054698A (hu) * 1964-12-04
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
DE4335454A1 (de) * 1993-10-19 1995-04-20 Schleicher Peter Geriatrikum
JPH09110708A (ja) * 1995-08-11 1997-04-28 Taisho Pharmaceut Co Ltd 滋養強壮用生薬配合製剤
JPH0959161A (ja) * 1995-08-23 1997-03-04 Taisho Pharmaceut Co Ltd 疲労改善用組成物
IT1277953B1 (it) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
IT1283951B1 (it) * 1996-03-15 1998-05-07 Mendes Srl Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
JPH10175856A (ja) * 1996-10-14 1998-06-30 Taisho Pharmaceut Co Ltd 疲労改善剤

Also Published As

Publication number Publication date
IT1299161B1 (it) 2000-02-29
AU750645B2 (en) 2002-07-25
HUP0101914A3 (en) 2002-12-28
ITRM980238A0 (it) 1998-04-17
IL139014A0 (en) 2001-11-25
SK15442000A3 (sk) 2001-06-11
BR9909712A (pt) 2000-12-26
NO20005128D0 (no) 2000-10-12
HUP0101914A2 (hu) 2002-03-28
EE200000601A (et) 2002-04-15
CA2328331A1 (en) 1999-10-28
KR20010042765A (ko) 2001-05-25
AU3442899A (en) 1999-11-08
TR200002894T2 (tr) 2001-01-22
NO20005128L (no) 2000-12-18
ITRM980238A1 (it) 1999-10-17
CN1299283A (zh) 2001-06-13
JP2002512191A (ja) 2002-04-23
EP1071424A1 (en) 2001-01-31
PL343482A1 (en) 2001-08-27
WO1999053921A1 (en) 1999-10-28

Similar Documents

Publication Publication Date Title
DE69933825D1 (de) Chemisch verstärkte Positivresistzusammensetzung
NO20032753L (no) Forbindelse og anvendelse derav
IS5850A (is) Andoxunar samsetning sem samanstendur af asetýl L-karnitíni og alfa-lípósýru
HK1024498A1 (en) Adhesive composition and adhesive sheet
DE69905371D1 (de) Härtbare zusammensetzung
HK1040939B (zh) 用於組織修復的組合物及其應用
HUP0104270A3 (en) Herbicidal composition and use thereof
DE69933544D1 (de) Polymer und härtbare zusammensetzung
EP0989459A4 (en) CHEMICALLY AMPLIFIED PROTECTIVE AGENT COMPOSITION
NO20006488D0 (no) Sammensetning og anvendelse
HU9903361D0 (en) Filter-device with collecting-vessel and with heating-device
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
EP1096316A4 (en) POSITIVELY WORKING RESIST COMPOSITION
PT1139761E (pt) Composicoes herbicidas e concentrados tensioactivos
DE69908455D1 (de) Kuvertiervorrichtung
IL138178A0 (en) Identifiable marking compositions and methods
EP1117084A4 (en) WRITING SYSTEM FOR NOTES
IS5663A (is) Samsetning sem samanstendur af L-karnitíni eða alkanóýl L-karnitíni og NADH og/eða NADHP
EP1056455A4 (en) EPIMORPHIN COMPOUND AND USE OF THE SAME
IS5235A (is) N-tríazólýl-2-indólkarboxamíð og notkun þeirra sem gallblöðruhreyfil-A gerandefni
NO20012973L (no) Polyester-polyuretanlim og anvendelsen derav
IS5816A (is) Andoxunarefni, andfjölgunarsamsetning, sem samanstendur af karnitíni og karótínóíði
GB9803232D0 (en) Compound composition and use
NO20006626D0 (no) Beleggingsmiddel og anvendelse herav
EP1090935A4 (en) FLUOROCOPOLYMER AND COMPOSITION THEREOF